Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Carmen Lau, PharmD, Valkal Bhatt, PharmD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Yeon Yoo, BS, Nelly G. Adel, PharmD, BCOP, BCPS, Chris Mazis, Miguel Perales, MD, Sergio A. Giralt, MD, Guenther Koehne, MD PhD, Doris M Ponce, MD, Genovefa A Papanicolaou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2219.

https://doi.org/10.1182/blood.V128.22.2219.2219

Published: 2016

Journal Articles

A Novel Intermediate Intensity Conditioning Regimen Achieves High Rates of Long-Term Outpatient Progression-Free Survival Offsetting the Disadvantage of Early Post-Transplant Complications in Adult Cord Blood (CB) Transplant Recipients

Ioannis Politikos, MD, Sean Devlin, PhD, Yeon Yoo, BS, Christopher Mazis, BS, Molly A. Maloy, MS, Andromachi Scaradavou, MD, Parastoo B. Dahi, MD, Miguel Perales, MD, Sergio Giralt, MD, Doris M Ponce, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2193.

https://doi.org/10.1182/blood.V128.22.2193.2193

Published: 2016

Journal Articles

Despite Increasing Size of Unrelated Donor (URD) Registries and the Global Cord Blood (CB) Inventory Racial Disparities in Access to URD and CB Grafts Persist: A Prospective 10 Year Analysis of 1,112 Patients

Kirsten Boughan, MD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Courtney Byam, BS, CHTC, Yeon Yoo, BS, Christopher Mazis, BS, Eric Davis, CHTC, Melissa Nhaissi, MPH, Jennifer Paulson, MBS, CHTC, Deborah Wells, MA, CHTC, Candice Cooper, BS, Doris M Ponce, MD, Sergio Giralt, MD, Esperanza B. Papadopoulos, MD, Nancy A. Kernan, MD, Andromachi Scaradavou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 821.

https://doi.org/10.1182/blood.V128.22.821.821

Published: 2016

Journal Articles

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Christina Cho, MD, Patrick Hilden, MS, Jonathan U. Peled, MD PhD, Scott T. Avecilla, MD PhD, Pere Barba, MD, Juliet N. Barker, MBBS (Hons), Hugo R. Castro-Malaspina, MD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Guenther Koehne, MD PhD, Richard C. Meagher, PhD, Molly A. Maloy, MS, Richard J. O'Reilly, MD, Esperanza B. Papadopoulos, MD, Doris M. Ponce, MD, Marcel R. M. van den Brink, MD PhD, James W. Young, MD, Miguel-Angel Perales, MD

Blood (2016) 128 (22): 3498.

https://doi.org/10.1182/blood.V128.22.3498.3498

Published: 2016

Journal Articles

Age-Adjusted Co-Morbidity Score - but Not Revised Disease Risk Index - Is Associated with Progression-Free Survival after Intermediate Intensity Double Unit CBT in Adults with Hematologic Malignancies

Blood (2015) 126 (23): 3231.

https://doi.org/10.1182/blood.V126.23.3231.3231

Published: 2015

Journal Articles

Successful Treatment of Refractory CMV Chorioretinitis and Meningoencephalitis with Adoptive Transfer of Third Party CMVpp65 Specific T-Cell Lines

Susan Prockop, MD, Aisha Hasan, MD, Ekaterina Doubrovina, MD PhD, H.R. Castro-Malaspina, MD, Juliet N. Barker, MBBS(Hons), FRACP, Parastoo B Dahi, MD, Farid Boulad, MD, Nancy A. Kernan, MD, Guenther Koehne, MD PhD, Craig S. Sauter, MD, Szilard Kiss, MD, Mrinali Patel, MD, Stephanie Suser, BA, Richard J O'Reilly, MD

Blood (2015) 126 (23): 3157.

https://doi.org/10.1182/blood.V126.23.3157.3157

Published: 2015

Journal Articles

Prospective Evaluation of Cord Blood (CB) & Haplo-Identical Donor Availability Reveals Compromised Donor Access for Both Graft Types in Minorities and High Rates of Failure to Clear Haplo Donors in Adult Patients

Satyajit Kosuri, MD, Tara F. Wolff, MS, NP-BC, Courtney Byam, BS, CHTC, Emily Lauer, BS, BA, Yeon Yoo, BS, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Andromachi Scaradavou, MD, Doris M Ponce, MD, Juliet N. Barker, MBBS (Hons)

Blood (2015) 126 (23): 2027.

https://doi.org/10.1182/blood.V126.23.2027.2027

Published: 2015

Journal Articles

A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Hodgkin Lymphoma

Miguel-Angel Perales, MD, Christina Cho, MD, Anne Eaton, MS, Alison J Moskowitz, MD, Victoria Nguyen, BS, Anne Marie R. Gonzales-Dadiz, BS, Sean Devlin, PhD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Matthew J. Matasar, MD MS, Ariela Noy, MD, Carol S. Portlock, MD, David J. Straus, MD, James W. Young, MD, Juliet N. Barker, MBBS(Hons), FRACP, Craig H. Moskowitz, MD

Blood (2015) 126 (23): 4383.

https://doi.org/10.1182/blood.V126.23.4383.4383

Published: 2015

Journal Articles

Successful Treatment of Peripheral T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: A Large Single-Center Experience

Neha Mehta-Shah, MD, Joanne Chou, Molly Maloy, MS, Zhigang Zhang, PhD, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Juliet N. Barker, MBBS(Hons), FRACP, Sergio Giralt, MD, Miguel-Angel Perales, MD, Steven M Horwitz, MD, Craig S. Sauter, MD, Parastoo B. Dahi, MD

Blood (2015) 126 (23): 4392.

https://doi.org/10.1182/blood.V126.23.4392.4392

Published: 2015

Journal Articles

The Abundance of Certain Bacteria in the Intestinal Flora Is Associated with Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Jonathan Peled, MD PhD, Eric R. Littman, Lilan Ling, Satyajit Kosuri, MD, Molly Maloy, MS, Sergio A. Giralt, MD, Juliet N. Barker, MBBS (Hons), Miguel-Angel Perales, MD, Ying Taur, MD, Eric Pamer, Marcel van den Brink, MD PhD, Robert R. Jenq, MD

Blood (2015) 126 (23): 744.

https://doi.org/10.1182/blood.V126.23.744.744

Published: 2015

Journal Articles

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients

Blood (2015) 126 (23): 4332.

https://doi.org/10.1182/blood.V126.23.4332.4332

Published: 2015

Journal Articles

Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical CD34+ Selected Peripheral Blood Stem Cells (PBSC) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection and Frequent Pre-Engraftment Syndrome

Blood (2014) 124 (21): 3903.

https://doi.org/10.1182/blood.V124.21.3903.3903

Published: 2014

Journal Articles

Day 45 Lymphocyte Recovery Is Independently Associated with Transplant-Related Mortality after Adult Myeloablative Double-Unit Cord Blood Transplantation (dCBT)

Duncan Purtill, FRACP,FRCPA,MBBS, Doris M. Ponce, MD, Sean M. Devlin, PhD, Marissa N Lubin, BA, Parastoo B Dahi, MD, Sergio A Giralt, MD, Miguel-Angel Perales, MD, Richard J. O'Reilly, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Andromachi Scaradavou, MD, Cladd Stevens, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1156.

https://doi.org/10.1182/blood.V124.21.1156.1156

Published: 2014

Journal Articles

Quantitative Assessment of T Cell Repertoire Recovery after Double Unit Cord Blood Transplantation Demonstrates Early T Cell Diversity and Correlation Between CMV Reactivation and CD8 Clonal Domimance

Miguel Perales, MD, Ying Taur, MD, Ingrid Leiner, MS, Marissa N Lubin, BA, Boze Susac, BA, Eric G. Pamer, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1158.

https://doi.org/10.1182/blood.V124.21.1158.1158

Published: 2014

Journal Articles

Successful Salvage of High-Risk B-Cell Non-Hodgkin and Hodgkin Lymphoma with Double-Unit Cord Blood Transplantation Provides a Platform for Further Optimization

Parastoo B Dahi, MD, Craig S. Sauter, MD, Sean M. Devlin, PhD, Marissa N Lubin, BA, Doris M. Ponce, MD, Sergio Giralt, MD, Guenther Koehne, MD PhD, Miguel-Angel Perales, MD, Andrew D. Zelenetz, MD PhD, Craig H. Moskowitz, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1258.

https://doi.org/10.1182/blood.V124.21.1258.1258

Published: 2014

Journal Articles

Comparable 3-Year Disease-Free Survival Regardless of Anti-Thymocyte Globulin Inclusion in Pediatric Myeloablative Cord Blood Transplantation for Acute Lymphoblastic Leukemia

Doris M. Ponce, MD, Rodney Sparapani, PhD, Junfang Chen, MS, Vanderson Rocha, MD PhD, Daniel H. Fowler, MD, Mary Eapen, MBBS, Juliet N. Barker, MBBS(Hons), FRACP, Miguel-Angel Perales, MD

Blood (2014) 124 (21): 1259.

https://doi.org/10.1182/blood.V124.21.1259.1259

Published: 2014

Journal Articles

Autoimmune Hemolysis & Immune Thrombocytopenic Purpura after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrants Early Therapy with Rituximab

Valkal Bhatt, PharmD, Leyla Shune, MD, Emily J Lauer, BS, BA, Marissa N Lubin, BA, Sean M. Devlin, PhD, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Sergio Giralt, MD, Rekha Parameswaran, MD, Miguel-Angel Perales, MD, Doris M. Ponce, MD, Gerald A. Soff, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1142.

https://doi.org/10.1182/blood.V124.21.1142.1142

Published: 2014

Journal Articles

Allogeneic Transplantation for Chronic Myelomonocytic Leukemia (CMML) Is Associated with High Disease-Free Survival Even in the Setting of High-Risk Disease

Matias Eugenio Sanchez, MD, Kamal Kant Singh Abbi, MBBS, Roni Tamari, MD, Ann Jakubowsky, MD PhD, Esperanza B Papadopoulos, MD, Sean M. Devlin, PhD, Weiji Shi, MS, Craig S. Sauter, MD, Juliet N. Barker, MBBS(Hons), FRACP, Farid Boulad, MD, Sergio Giralt, MD, Richard Meagher, MD, Hugo Castro-Malaspina, MD

Blood (2014) 124 (21): 2575.

https://doi.org/10.1182/blood.V124.21.2575.2575

Published: 2014

Journal Articles

Myeloablative Double-Unit Cord Blood Transplantation (CBT) in Pediatric Patients with High-Risk Acute Leukemia Demonstrates Encouraging Disease-Free Survival with Both TBI and Chemotherapy-Only-Based Conditioning

Andromachi Scaradavou, MD, Marissa N Lubin, BA, Patrick Hilden, MS, Farid Boulad, MD, Kevin J. Curran, MD, Rachel Kobos, MD, Susan E. Prockop, MD, Richard J. O'Reilly, MD, Jo-Ann Tonon, Courtney Byam, BS, Peter G Steinherz, MD, Neerav Shukla, MD, Aisha Hasan, MD, Thomas M. Renaud, MD, Nicole Zakak, N.P., Nancy A. Kernan, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2578.

https://doi.org/10.1182/blood.V124.21.2578.2578

Published: 2014

Journal Articles

Analysis of 129 Myeloablative Double-Unit Cord Blood Transplantation Recipients Demonstrates an Independent Association Between Non-Dominant Unit TNC Dose and Engraftment Suggesting a Facilitation Effect

Duncan Purtill, FRACP,FRCPA,MBBS, Marissa N Lubin, BA, Doris M. Ponce, MD, Sergio Giralt, MD, Miguel-Angel Perales, MD, Richard J O'Reilly, MD, Marcel Van Den Brink, MD PhD, James W. Young, MD, Andromachi Scaradavou, MD, Cladd Stevens, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2459.

https://doi.org/10.1182/blood.V124.21.2459.2459

Published: 2014

NARROW

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

A Novel Intermediate Intensity Conditioning Regimen Achieves High Rates of Long-Term Outpatient Progression-Free Survival Offsetting the Disadvantage of Early Post-Transplant Complications in Adult Cord Blood (CB) Transplant Recipients

Despite Increasing Size of Unrelated Donor (URD) Registries and the Global Cord Blood (CB) Inventory Racial Disparities in Access to URD and CB Grafts Persist: A Prospective 10 Year Analysis of 1,112 Patients

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Age-Adjusted Co-Morbidity Score - but Not Revised Disease Risk Index - Is Associated with Progression-Free Survival after Intermediate Intensity Double Unit CBT in Adults with Hematologic Malignancies

Successful Treatment of Refractory CMV Chorioretinitis and Meningoencephalitis with Adoptive Transfer of Third Party CMVpp65 Specific T-Cell Lines

Prospective Evaluation of Cord Blood (CB) & Haplo-Identical Donor Availability Reveals Compromised Donor Access for Both Graft Types in Minorities and High Rates of Failure to Clear Haplo Donors in Adult Patients

A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Hodgkin Lymphoma

Successful Treatment of Peripheral T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: A Large Single-Center Experience

The Abundance of Certain Bacteria in the Intestinal Flora Is Associated with Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients

Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical CD34+ Selected Peripheral Blood Stem Cells (PBSC) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection and Frequent Pre-Engraftment Syndrome

Day 45 Lymphocyte Recovery Is Independently Associated with Transplant-Related Mortality after Adult Myeloablative Double-Unit Cord Blood Transplantation (dCBT)

Quantitative Assessment of T Cell Repertoire Recovery after Double Unit Cord Blood Transplantation Demonstrates Early T Cell Diversity and Correlation Between CMV Reactivation and CD8 Clonal Domimance

Successful Salvage of High-Risk B-Cell Non-Hodgkin and Hodgkin Lymphoma with Double-Unit Cord Blood Transplantation Provides a Platform for Further Optimization

Comparable 3-Year Disease-Free Survival Regardless of Anti-Thymocyte Globulin Inclusion in Pediatric Myeloablative Cord Blood Transplantation for Acute Lymphoblastic Leukemia

Autoimmune Hemolysis & Immune Thrombocytopenic Purpura after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrants Early Therapy with Rituximab

Allogeneic Transplantation for Chronic Myelomonocytic Leukemia (CMML) Is Associated with High Disease-Free Survival Even in the Setting of High-Risk Disease

Myeloablative Double-Unit Cord Blood Transplantation (CBT) in Pediatric Patients with High-Risk Acute Leukemia Demonstrates Encouraging Disease-Free Survival with Both TBI and Chemotherapy-Only-Based Conditioning

Analysis of 129 Myeloablative Double-Unit Cord Blood Transplantation Recipients Demonstrates an Independent Association Between Non-Dominant Unit TNC Dose and Engraftment Suggesting a Facilitation Effect

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only